Enfortumab vedotin-ejfv

1346452-25-2

Nectin-4|||Antibody-Drug Conjugates (ADCs)

Antibody-drug Conjugate/ADC Related|||Immunology/Inflammation

Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma.

Cool pack

-20°C

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TRC-U847045-25MG 25 mg

Ask

NBP3-08236UV 100 µL

Ask

TA346721 100 µL

Ask

GTR15390686 1 Vial

Ask

403033-01 50 µL

Ask

403033-02 100 µL

Ask